Strategies for University Hospitals Forum is where senior leadership from both the public and private sectors can meet to share, learn and partner to solve the considerable management challenges that university hospitals, academic medical centres and research institutes face.
Solutions are seldom found in the silos that exist and this forum has been designed to be a catalyst for change. Facilitating conversation between global stakeholders seeking the same ultimate goal.
Strategic Partners
Agenda for University Hospitals and Research Institutes
The theme for 2023 Strategies for University Hospitals Forum is Scaling up for the Genetics and Data Revolution.
This half day leadership forum aims to address the urgent, burning question for all university hospitals as new guidelines enforce the roll out of mass genetic testing, particularly in oncology. Whilst also recognising the need to adopt population health management systems and linking them to primary care.
Keynote sessions and speakers on Monday, June 19 currently include:
12.00-13.00 Keynote discussion: Challenges and Solutions Neil Wright, Commercial Director, Guy’s and St Thomas NHS Foundation Trust Prof Anna Wedell, Director, Precision Medicine, Karolinska Ran Balicer, Chief Innovation Officer, Clalit
14.00-14.30 Keynote: Implementing Personalised Medicine in a University Hospital Setting Prof Anna Wedell, Director, Precision Medicine Center, Karolinska
14.30-15.00 Building population health management solutions
15.30-16.00 Keynote: Deeper Partnering Neil Wright, Commercial Director, Guy’s and St Thomas NHS Foundation Trust
16.30-17.30 Partnering and Innovation Workshops
17.30-18.00 Building Massive Data Platforms Prof John Gallacher, Director, Dementia Platforms UK, Oxford University
HBI 2023
The Strategies for University Hospitals forum is part of HBI 2023, the largest CEO event in health and care services held annually in London. Public sector delegates attending the half-day forum on June 19th is also invited to attend the main HBI conference held on June 20 and 21, at a highly subsidised rate.
Attending HBI 2023 will provide the opportunity to continue to meet with global leaders from across the sector, whilst also participating in the following highly relevant sessions and workshops ranging from workforce, through to the impact of digital transformation, AI, efficiency and ESG.
June 20 - Day 2
Day two includes the following highly relevant sessions:
09.00 – 10.00 The 2023 Healthcare M&A Landscape – an overview of how M&A is driving health care services in the for-profit sector
11.30 – 12.30 Healthcare Regulation 2023 and beyond
12.30 – 13.30 Building the best business models for digital
13.30 – 14.30 Networking Lunch
14.30 – 15.30 Lessons in innovation from across the pond
16.15 – 17.15 The race for the first mile
17.15 – 18.15 Building a sustainable health workforce
June 21 - Day 3
Day three includes:
09.00 – 10.00 Building a robust ESG framework
10.00 – 11.00 How to develop my ESG framework
11.00 – 11.30 Networking break
11.30 – 12.30 Virtual wards and outpatient clinics: Embracing the future for hospitals
12.30 – 13.30 Networking Lunch
13.30 – 14.30 Imaging Diagnostics: the Care Gateway
14.30 – 15.30 Evolution in Primary Care
15.30 – 16.30 What we’ve learnt
What we offer
Why you should attend
- Tackle your burning issues – You’ll find sessions on partnering, workforce/culture, brand and digital business models.
- Understand how the sector is changing globally – How will Big Tech impact the sector? Who will win the first mile of diagnostics? Who are building international service platforms?
- Environmental, Social and Governance are becoming ever more important. You’ll find sessions where CEOs discuss the nuts and bolts of how to implement robust ESG.
- CEO-level case studies – This is the forum where CEOs talk frankly about their issues and challenges.
- Meet potential partners – The economic crisis means university hospitals increasingly need to reach out beyond the public sector and consider how to best build win/win relationships with service providers, big medtech and big pharma. This is the best forum to discuss these issues.
Who should attend?
Apart from CEOs and Chief Medical Officers, this forum is highly relevant to directors of strategy, partnership, business development and cultural change. Many organisations send entire management teams to HBI.